Brentuximab vedotin plus nivolumab as bridging therapy to CAR T-cells in relapsed/refractory Primary Mediastinal B-Cell Lymphoma
Year: 2025
Type: article
Abstract: Not available.
Source: Haematologica
Institutions: Humanitas University, IRCCS Humanitas Research Hospital
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W4414339079
FWCI:
Cites:
Cited by:
Related to: